Related references
Note: Only part of the references are listed.Gapped sequence alignment using artificial neural networks: application to the MHC class I system
Massimo Andreatta et al.
BIOINFORMATICS (2016)
Mass spectrometry-based antigen discovery for cancer immunotherapy
Michal Bassani-Sternberg et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Neoantigens encoded in the cancer genome
Ton N. Schumacher et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Analyzing the effect of peptide-HLA-binding ability on the immunogenicity of potential CD8+and CD4+T cell epitopes in a large dataset
Shufeng Wang et al.
IMMUNOLOGIC RESEARCH (2016)
Pan-Specific Prediction of Peptide-MHC Class I Complex Stability, a Correlate of T Cell Immunogenicity
Michael Rasmussen et al.
JOURNAL OF IMMUNOLOGY (2016)
The Length Distribution of Class I-Restricted T Cell Epitopes Is Determined by Both Peptide Supply and MHC Allele-Specific Binding Preference
Thomas Trolle et al.
JOURNAL OF IMMUNOLOGY (2016)
Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
Michal Bassani-Sternberg et al.
NATURE COMMUNICATIONS (2016)
NetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasets
Morten Nielsen et al.
GENOME MEDICINE (2016)
AIRE expands: new roles in immune tolerance and beyond
Mark S. Anderson et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Automated benchmarking of peptide-MHC class I binding predictions
Thomas Trolle et al.
BIOINFORMATICS (2015)
Immunogenic peptide discovery in cancer genomes
Alexandra Snyder et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2015)
Discovering protective CD8 T cell epitopes - no single immunologic property predicts it!
Pavlo Gilchuk et al.
CURRENT OPINION IN IMMUNOLOGY (2015)
New York esophageal squamous cell carcinoma-1 and cancer immunotherapy
Ali Esfandiary et al.
IMMUNOTHERAPY (2015)
TCR contact residue hydrophobicity is a hallmark of immunogenic CD8+ T cell epitopes
Diego Chowell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
Immunoinformatics and epitope prediction in the age of genomic medicine
Linus Backert et al.
GENOME MEDICINE (2015)
Structural basis for ineffective T-cell responses to MHC anchor residue-improved heteroclitic peptides
Florian Madura et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Role of peptide processing predictions in T cell epitope identification: contribution of different prediction programs
Jorg J. A. Calis et al.
IMMUNOGENETICS (2015)
NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus
Ji-Li Chen et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
NetTepi: an integrated method for the prediction of T cell epitopes
Thomas Trolle et al.
IMMUNOGENETICS (2014)
NETMHCSTAB - predicting stability of peptide-MHC-I complexes; impacts for cytotoxic T lymphocyte epitope discovery
Kasper W. Jorgensen et al.
IMMUNOLOGY (2014)
Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity
Fei Duan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Enhancement of an anti-tumor immune response by transient blockade of central T cell tolerance
Imran S. Khan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Improved pan-specific MHC class I peptide-binding predictions using a novel representation of the MHC-binding cleft environment
S. Carrasco Pro et al.
TISSUE ANTIGENS (2014)
HLA-Binding Properties of Tumor Neoepitopes in Humans
Edward F. Fritsch et al.
CANCER IMMUNOLOGY RESEARCH (2014)
High sensitivity of cancer exome-based CD8 T cell neo-antigen identification
Marit M. van Buuren et al.
ONCOIMMUNOLOGY (2014)
Peptide Modulation of Class I Major Histocompatibility Complex Protein Molecular Flexibility and the Implications for Immune Recognition
William F. Hawse et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
HLA-A*01:03, HLA-A*24:02, HLA-B*08:01, HLA-B*27:05, HLA-B*35:01, HLA-B*44:02, and HLA-C*07:01 Monochain Transgenic/H-2 Class I Null Mice: Novel Versatile Preclinical Models of Human T Cell Responses
Rachid Boucherma et al.
JOURNAL OF IMMUNOLOGY (2013)
Properties of MHC Class I Presented Peptides That Enhance Immunogenicity
Jorg J. A. Calis et al.
PLOS COMPUTATIONAL BIOLOGY (2013)
Identification of Conserved and HLA Promiscuous DENV3 T-Cell Epitopes
Eduardo J. M. Nascimento et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
T-Cell Memory Responses Elicited by Yellow Fever Vaccine are Targeted to Overlapping Epitopes Containing Multiple HLA-I and -II Binding Motifs
Andrea Barbosa de Melo et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
Prediction of HLA class I-restricted T-cell epitopes of islet autoantigen combined with binding and dissociation assays
Xiangmei Wu et al.
AUTOIMMUNITY (2012)
Peptide-MHC class I stability is a better predictor than peptide affinity of CTL immunogenicity
Mikkel Harndahl et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Seq2Logo: a method for construction and visualization of amino acid binding motifs and sequence profiles including sequence weighting, pseudo counts and two-sided representation of amino acid enrichment and depletion
Martin Christen Frolund Thomsen et al.
NUCLEIC ACIDS RESEARCH (2012)
Immune epitope database analysis resource
Yohan Kim et al.
NUCLEIC ACIDS RESEARCH (2012)
Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients
Kunle Odunsi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
HLA-A*0201-restricted CD8+ T-cell epitopes identified in dengue viruses
Zhi-Liang Duan et al.
VIROLOGY JOURNAL (2012)
An efficient T-cell epitope discovery strategy using in silico prediction and the iTopia assay platform
Arthur Fridman et al.
ONCOIMMUNOLOGY (2012)
Loss of T Cell Antigen Recognition Arising from Changes in Peptide and Major Histocompatibility Complex Protein Flexibility IMPLICATIONS FOR VACCINE DESIGN
Francis K. Insaidoo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Prediction of epitopes using neural network based methods
Claus Lundegaard et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2011)
Real time detection of peptide-MHC dissociation reveals that improvement of primary MHC-binding residues can have a minimal, or no, effect on stability
Kim M. Miles et al.
MOLECULAR IMMUNOLOGY (2011)
Human Leukocyte Antigen (HLA) Class I Restricted Epitope Discovery in Yellow Fewer and Dengue Viruses: Importance of HLA Binding Strength
Ole Lund et al.
PLOS ONE (2011)
Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen (HLA)-B*0702 and HLA-B*0801 alleles in TB10.4 CD8+T-cell responses
Rebecca Axelsson-Robertson et al.
IMMUNOLOGY (2010)
The Immune Epitope Database 2.0
Randi Vita et al.
NUCLEIC ACIDS RESEARCH (2010)
The PickPocket method for predicting binding specificities for receptors based on receptor pocket similarities: application to MHC-peptide binding
Hao Zhang et al.
BIOINFORMATICS (2009)
HLA Class I-Associated Immunodominance Affects CTL Responsiveness to an ESO Recombinant Protein Tumor Antigen Vaccine
Gilles Bioley et al.
CLINICAL CANCER RESEARCH (2009)
Vaccination With a Recombinant Protein Encoding the Tumor-specific Antigen NY-ESO-1 Elicits an A2/157-165-specific CTL Repertoire Structurally Distinct and of Reduced Tumor Reactivity Than That Elicited by Spontaneous Immune Responses to NY-ESO-1-expressing Tumors
Gilles Bioley et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Peptide Binding to HLA Class I Molecules: Homogenous, High-Throughput Screening, and Affinity Assays
Mikkel Harndahl et al.
JOURNAL OF BIOMOLECULAR SCREENING (2009)
Accurate approximation method for prediction of class I MHC affinities for peptides of length 8, 10 and 11 using prediction tools trained on 9mers
Claus Lundegaard et al.
BIOINFORMATICS (2008)
NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11
Claus Lundegaard et al.
NUCLEIC ACIDS RESEARCH (2008)
Tumor-reactive CD8+ T-cell clones in patients after NY-ESO-1 peptide vaccination
Julia Karbach et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Epitope clustering in regions undergoing efficient proteasomal processing defines immunodominant CTL regions of a tumor antigen
Danila Valmori et al.
CLINICAL IMMUNOLOGY (2007)
Recombinant vaccinia/fowipox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients
Elke Jaeger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Relating TCR-peptide-MHC affinity to immunogenicity for the design of tumor vaccines
Rachel H. McMahan et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Striking immunodominance hierarchy of naturally occurring CD8+ and CD4+ T cell responses to tumor antigen NY-ESO-1
Heather Jackson et al.
JOURNAL OF IMMUNOLOGY (2006)
Structural and kinetic basis for heightened immunogenicity of T cell vaccines
JL Chen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage
M Nielsen et al.
IMMUNOGENETICS (2005)
A mouse model of human adaptive immune functions:: HLA-A2.1-/HLA-DR1-transgenic H-2 class I-/class II-knockout mice
A Pajot et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Soluble major histocompatibility complex-peptide Octamers with impaired CD8 binding selectively induce Fas-dependent apoptosis
P Guillaume et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Multiepitope CD8+ T cell response to an NY-ESO-1 peptide vaccine results in imprecise tumor targeting
V Dutoit et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
CD8+ T cell responses against a dominant cryptic HLA-A2 epitope after NY-ESO-1 peptide immunization of cancer patients
S Gnjatic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Exogenous peptides presented by transporter associated with antigen processing (TAP)-deficient and TAP-competent cells: Intracellular loading and kinetics of presentation
T Luft et al.
JOURNAL OF IMMUNOLOGY (2001)
CD4+ T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele:: Association with NY-ESO-1 antibody production
G Zeng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
